Search Within

Enrico Moiso

Formats
  1. Meeting Abstract (7)
  2. Journal Article (2)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (6)
  2. Breast Medicine Service (6)
  3. Department of Medicine (6)
  4. GSK Faculty (6)
  5. Human Oncology and Pathogenesis Program (6)
  6. Solid Tumor Oncology Division (6)

More Groups

People
  1. Pedram Razavi (6)
  2. Sarat Chandarlapaty (6)
  3. Anton Safonov (5)
  4. Luc Cabel (5)
  5. Mark Robson (4)
  6. Ah Reum An (3)

More People

Years
  1. 2025 (1)
  2. 2024 (8)
Publications
  1. Journal of Clinical Oncology (4)
  2. Febs Open Bio (2)
  3. Annals of Oncology (1)
  4. Cancer Cell (1)
  5. Molecular Cancer (1)
Publishers
  1. American Society of Clinical Oncology (4)
  2. Wiley Blackwell (2)
  3. Biomed Central Ltd (1)
  4. Cell Press (1)
  5. Oxford University Press (1)

Results (9)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Ultrasensitive ctDNA monitoring during CDK4/6 inhibitor therapy for metastatic breast cancer
    Meeting Abstract

    Ah-Reum An, J.; Jasper, J.; Cabel, L.; Yildirim, S. Y.; da Silva, E. M.; Patel, R. K.; LaBella, M.; Teysir, J.; Mai, N.; Safonov, A.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Concordance of PI3K-AKT pathway alterations between tumor and ctDNA in metastatic breast cancer
    Meeting Abstract

    Tsai, C.; An, J. A. R.; Cabel, L.; Brannon, A. R.; Moiso, E.; Gedvilaite, E.; Ahmed, M.; Loudon, L.; Weipert, C.; Chou, J.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • NAMPT inhibition impairs mTOR-dependent regulation of translation in melanoma
    Meeting Abstract

    Todesco, A. M.; Fiorilla, I.; Ponzone, L.; Ponzano, A.; Moiso, E.; De Giorgis, V.; Ghezzi, B.; Landi, C.; Manfredi, M.; Calautti, V.; more...
    Febs Open Bio (2024)

    Fulltext@MSK | Save
  • Nicotinamide phosphoribosyltransferase (NAMPT) is over-expressed and abundantly released from malignant pleural mesothelioma becoming a potential biomarker
    Meeting Abstract

    Fiorilla, I.; Mazzola, F.; Todesco, A. M.; Moiso, E.; Piacente, F.; Ponzano, A.; Libener, R.; Grosso, F.; Bruzzone, S.; Raffaelli, N.; more...
    Febs Open Bio (2024)

    Fulltext@MSK | Save
  • Long-term breast cancer response to CDK4/6 inhibition defined by TP53-mediated geroconversion
    Journal Article

    Kudo, R.; Safonov, A.; Jones, C.; Moiso, E.; Dry, J. R.; Shao, H.; Nag, S.; da Silva, E. M.; Yildirim, S. Y.; Li, Q.; more...
    Cancer Cell (2024)

    Fulltext@MSK | Save
  • Personalized circulating tumor DNA for minimal residual disease and dynamic assessment in patients undergoing neoadjuvant chemotherapy for breast cancer: Preliminary analysis from MSK-LINC
    Meeting Abstract

    Kim, H. K.; An, J. A. R.; Smith, C. G.; Kim, J.; Cabel, L.; Moiso, E.; Ferraro, E.; Safonov, A.; Nelson, K.; Szuhany, K.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Overall survival analysis of first line CDK4/6 inhibitors in a large real-world cohort of patients with hormone receptor-positive (HR+)/HER2-negative metastatic breast cancer
    Meeting Abstract

    Ferraro, E.; Moiso, E.; Safonov, A.; Cabel, L.; Loudon, L.; Dang, C. T.; Shen, S.; Jhaveri, K. L.; Robson, M. E.; Chandarlapaty, S.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Predicting CDK4/6 inhibitors outcomes in pts with HR+/HER2-metastatic breast cancer: A machine learning approach
    Meeting Abstract

    Moiso, E.; Ferraro, E.; Cabel, L.; Safonov, A.; Ahmed, M.; An, J. A. R.; Jhaveri, K. L.; Norton, L.; Robson, M. E.; Modi, S.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • RICTOR/mTORC2 downregulation in BRAF(V600E) melanoma cells promotes resistance to BRAF/MEK inhibition
    Journal Article

    Ponzone, L.; Audrito, V.; Landi, C.; Moiso, E.; Levra Levron, C.; Ferrua, S.; Savino, A.; Vitale, N.; Gasparrini, M.; Avalle, L.; more...
    Molecular Cancer (2024)

    Fulltext@MSK | Save